A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Plasma Pharmacokinetics and Lung Penetration of Intravenous (IV) ACHN-490 in Healthy Subjects.

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Plasma Pharmacokinetics and Lung Penetration of Intravenous (IV) ACHN-490 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Apr 2013

At a glance

  • Drugs Plazomicin (Primary)
  • Indications Bacterial infections; Pyelonephritis; Respiratory tract infections; Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 28 Apr 2013 Results presented at the 23rd European Congress of Clinical Microbiology and Infectious Diseases.
    • 12 Sep 2011 Results published in Antimicrobial Agents and Chemotherapy.
    • 04 Oct 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top